Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

956 evidence items · page 5 / 39

13.2 %Au Burkina Faso, l'examen microscopique a détecté une prévalence de 13,2 % d'infections à P. malariae chez 830 enfants âgés de trois à quinze ans.

Burkina FasopaludismeHAL · Unilimdocument of 80 observations

7.5 %Among SARS-CoV-2 cases in Burkina Faso as of 21 June 2020, 7.5% of deaths occurred in the 30–44 age group.

Burkina FasoCOVID-19observed 21 June 2020HAL · Unilimdocument of 97 observations

707 per_1000En 2022, l'incidence du paludisme pendant la grossesse était de 707 pour 1000 femmes au Burkina Faso.

Burkina Fasopaludismeobserved 2022HAL · Unilimdocument of 302 observations

24 %Human Salmonella isolates showed 24% resistance to cephalosporins.

Burkina FasoSalmonellapublished 2026Microorganismseurope_pmcdocument of 6 observations

21.65 minutesThe mean duration of swarming was 21 minutes and 39 seconds for Anopheles coluzzii.

Burkina Fasopaludismepublished 2013Parasites & vectorseurope_pmcdocument of 7 observationsDOI 10.1186/1756-3305-6-275

4.53 %In Sector 8, the morbidity rate for severe malaria among children under 5 years of age was 4.53% in 2023.

Burkina Fasopaludismeobserved 2023HAL · Unilimdocument of 110 observations

59.7 %The parasite positivity rate decreased from 59.7% on day 1 to 6.7% on day 2 and 0.9% on day 3 among patients with uncomplicated malaria treated with artemisinin-based combination therapies in Sub-Saharan Africa.

Burkina Fasopaludismepublished 2015BMC medicineeurope_pmcdocument of 11 observations

2 samplesQuintuple dhfr-dhps mutants were present in 2 delivery samples and 4 general population samples in Nanoro, Burkina Faso.

Burkina Fasopaludismepublished 2017Molecular and biochemical parasitologyeurope_pmcdocument of 2 observations

4 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 4% showed a 10-fold increase in anti-CSP IgG antibody titres post-2021 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobserved post-2021HAL · Unilimdocument of 105 observations

Occurrence of anaemia was associated with high Plasmodium falciparum parasitaemia.

Burkina Fasopaludismepublished 2017Malaria journaleurope_pmcdocument of 16 observations

Moderate levels of insecticide resistance were observed in Vallée du Kou (VK) to carbamates.

Burkina Fasopaludismepublished 2013Geneeurope_pmcdocument of 6 observations

125 per_1000L'incidence cumulée du paludisme pendant la grossesse était de 125 pour 1000 femmes enceintes à risque au Burkina Faso dans le bras intervention comparé au bras contrôle.

Burkina FasopaludismeHAL · Unilimdocument of 302 observations

69 casesAmong diagnosed patients, bacteremia accounted for 69 cases.

Burkina Fasobacteraemiapublished 2021PLoS neglected tropical diseaseseurope_pmcdocument of 11 observations

9.583 minutesAnopheles gambiae males became active in the actograph 9 minutes and 35 seconds earlier than Anopheles coluzzii males.

Burkina Fasopaludismepublished 2013Parasites & vectorseurope_pmcdocument of 7 observationsDOI 10.1186/1756-3305-6-275

22 patientsCombining blood culture and 16S metagenomics results diagnosed bacterial bloodstream infection in 22 patients among 75 children with severe febrile illness in Burkina Faso.

Burkina Fasobacterial bloodstream infectionpublished 2016PLoS neglected tropical diseaseseurope_pmcdocument of 4 observations

11,097 patientsA total of 11,097 patients were screened for confirmed uncomplicated malaria in an observational study conducted in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobserved September 2013 to April 2014published 2016Malaria journaleurope_pmcdocument of 6 observations

9.1 %Of 198 blood donor samples tested in Ouagadougou, Burkina Faso, 18 (9.1%) were positive for at least one of Cytomegalovirus (CMV), Epstein-Barr virus (EBV), or Herpes virus 6 (HHV-6).

Burkina FasoCytomegalovirus · Herpes virus 6 · virus Epstein-Barrpublished 2016The Pan African medical journaleurope_pmcdocument of 8 observations

30 %High proportions of isolates with multiple copies of the Pfpm2 gene, associated with piperaquine resistance, were frequently observed in African sites, especially in Burkina Faso and Uganda, exceeding 30%.

Burkina Faso · Ougandapaludismepublished 2019Malaria journaleurope_pmcdocument of 2 observationsDOI 10.1186/s12936-019-2756-4

20.3 %The prevalence of toxoplasmosis among pregnant women in Ouagadougou, Burkina Faso was 20.3%.

Burkina Fasotoxoplasmosepublished 2012Asian Pacific journal of tropical medicineeurope_pmcdocument of 8 observations

7 daysThe average onset of SARS-CoV-2 PCR negativity was estimated at 7.0 days.

Burkina FasoCOVID-19observed 2020published 2021Therapeutics and clinical risk managementeurope_pmcdocument of 6 observations

1 caseOne case of abortion was reported among participants receiving artemisinin-based combination therapies in Burkina Faso.

Burkina Fasopaludismeobserved 2010–2012published 2020Drug design, development and therapyeurope_pmcdocument of 5 observations

5.1 %Among 198 blood donors in Ouagadougou, Burkina Faso, 10 (5.1%) were positive for Cytomegalovirus (CMV).

Burkina FasoCytomegaloviruspublished 2016The Pan African medical journaleurope_pmcdocument of 8 observations

90 %The proportion of positive responders to CHO-rPvs48/45 was 90% in Burkina Faso.

Burkina FasopaludismeHAL · Unilimdocument of 25 observations

21 %In 2018, the combined intervention of seasonal RTS,S/AS01 E malaria vaccination with seasonal malaria chemoprevention (SMC) reduced the prevalence of wasting by approximately 21% compared to SMC alone.

Burkina Faso · Malipaludismeobserved 2018published 2022Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/s12936-022-04077-x

0.82 AUCA simple corticosteroid signature was a good classifier of severe malaria and non-malaria febrile patients with an AUC of 0.82.

Burkina Fasonon-malaria febrile illness · paludismepublished 2016PLoS neglected tropical diseaseseurope_pmcdocument of 3 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.